100 Infusion Products Got Price Raises under Unprofitability Re-Pricing, but Drastic Pricing Reform Still Necessary: IV Solution Society

Junji Shiomi, chairman of the Intravenous Solution Society’s drug pricing committee Around 100 infusion fluid products saw their prices shored up under a re-pricing rule for unprofitable drugs in the FY2018 drug price revision in April, but so many products...read more